Live: Will Tonight’s Q2 Earnings Report Send Vertex Pharmaceuticals Higher?
Vertex Pharmaceuticals drops its Q2 2026 results tonight with a $10 billion acquisition just closed, a blockbuster pain drug launch in full swing, and analysts watching one kidney disease drug that could redefine the…



















